Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, whereas semaglutide activates only the GLP-1 receptor and tirzepatide targets both GIP and GLP-1 receptors
Long-term, GLP-1 medications appear to lower uric acid and reduce flares
How to Use Creatine Effectively for Weight Loss Goals If you've decided to add creatine to your weight loss plan, here's how to get the most out of it without unnecessary complications: Recommended Dosage and Timing Daily dose: Common supplemental protocols often use a consistent daily amount, and guidance can vary by individual
Refractory SLE patients respond to the proteasome inhibitor bortezomib
If you are low on NAD+, your body has to choose: "Do I fix the DNA or do I make energy?" It can't do both well, which leads to aging
A certificate of analysis is only as trustworthy as its weakest link